Inorganic arsenic induces necrosis of human CD34-positive haematopoietic stem cells

Environmental Toxicology

Volumn 23, Issue 2, 2008, Pages 263-268

  Vernhet, Laurent ^a   Morzadec, Claudie ^a   Van Grevenynghe, Julien ^a   Bareau, Benoît ^b   Corolleur, Michel ^b   Fest, Thierry ^b   Fardel, Olivier ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Arsenic; CD34 positive cells; Human progenitors; Immunotoxicity

Indexed keywords

ARSENIC COMPOUNDS; CELL PROLIFERATION; TOXICITY;

INORGANIC ARSENIC; NECROTIC PROCESS; STEM CELLS;

INORGANIC COMPOUNDS;

ARSENIC TRIOXIDE; CASPASE; CD34 ANTIGEN;

ARSENIC; CYTOLOGY; IMMUNOASSAY; MITOCHONDRION; TOXICITY TEST;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD34; ARSENICALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; HEMATOPOIETIC STEM CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NECROSIS; OXIDES;

EID: 41449115303     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20334     Document Type: Article

References (25)

1. Abernathy CO, Thomas DJ, Calderon RL. 2003. Health effects and risk assessment of arsenic. J Nutr 133 (5 Suppl 1):1536S-1538S.
2. Abernethy DJ, Kleymenova EV, Rose J, Recio L, Faiola B. 2004. Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone. Toxicol Sci 79:82-89.
3. Bartolovic K, Balabanov S, Hartmann U, Komor M, Boehmler AM, Buhring HJ, Mohle R, Hoelzer D, Kanz L, Hofmann WK, Brümmendorf TH. 2004. Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood 103:523-529.
4. Chen GQ, Zhou L, Styblo M, Walton F, Jing Y, Weinberg R, Chen Z, Waxman S. 2003. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Cancer Res 63:1853-1859.
5. 2-terminal kinase and up-regulation of death receptors. Cancer Res 66:11416-11423.
6. Dai J, Weinberg RS, Waxman S, Jing Y. 1999. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268-277.
7. Galicia G, Leyva R, Tenorio EP, Ostrosky-Wegman P, Saavedra R. 2003. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int Immunopharmacol 3:671-682.
8. Gupta S, Yel L, Kim D, Kim C, Chiplunkar S, Gollapudi S. 2003. Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: A role of Bcl-2. Mol Cancer Ther 2:711-719.
9. 3)-induced apoptosis in human glioblastoma cells. Cancer Sci 96:825-833.
10. Hall AH. 2002. Chronic arsenic poisoning. Toxicol Lett 128:69-72.
11. Heidel SM, MacWilliams PS, Baird WM, Dashwood WM, Buters JT, Gonzalez FJ, Larsen MC, Czuprynski CJ, Jefcoate CR. 2000. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7, 12-dimethylbenz[a]anthracene. Cancer Res 60:3454-3460.
12. Islam LN, Nabi AH, Rahman MM, Khan MA, Kazi AI. 2004. Association of clinical complications with nutritional status and the prevalence of leukopenia among arsenic patients in Bangladesh. Int J Environ Res Public Health 1:74-82.
13. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. 2005. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24:980-991.
14. Kohler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, Ehninger G, Bornhauser M. 1999. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 17:19-24.
15. Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L. 2006a. Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol 177:3019-3027.
16. Lemarie A, Morzadec C, Merino D, Micheau O, Fardel O, Vernhet L. 2006b. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-κB-related survival pathway down-regulation. J Pharmacol Exp Ther 316:304-314.
17. McCabe MJ Jr, Singh KP, Reddy SA, Chelladurai B, Pounds JG, Reiners JJ Jr, States JC. 2000. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. J Pharmacol Exp Ther 295:724-733.
18. Morgan GJ, Alvares CL. 2005. Benzene and the hemopoietic stem cell. Chem Biol Interact 153-154:217-222.
19. Nutt LK, Gogvadze V, Uthaisang W, Mirnikjoo B, McConkey DJ, Orrenius S. 2005. Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis. Cancer Biol Ther 4: 459-467.
20. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, Endo A, Yu L, Yuki K, Miyauchi T, Shimojo N. 2000. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 28:1137-1142.
21. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D, Biswas BK, Chanda CR, Basu GK, Saha KC, et al. 2001. Chronic arsenic toxicity in Bangladesh and West Bengal, India - A review and commentary. J Toxicol Clin Toxicol 39: 683-700.
22. Scholz C, Wieder T, Starck L, Essmann F, Schulze-Osthoff K, Dorken B, Daniel PT. 2005. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 24:1904-1913.
23. Soto-Pena GA, Luna AL, Acosta-Saavedra L, Conde P, Lopez-Carrillo L, Cebrian ME, Bastida M, Calderon-Aranda ES, Vega L. 2006. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J 20:779-781.
24. van Grevenynghe J, Bernard M, Langouet S, Le Berre C, Fest T, Fardel O. 2005. Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther 314:693-702.
25. Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S. 2003. The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines. Acta Haematol 110:1-10.